In the Western countries, the incidence of esophageal carcinoma is 3-6 cases per 100.000 persons. Despite tremendous success of other therapeutic options, surgical treatment still represents the best therapeutic option whenever possible. For the long period, debate has centered on which of the available surgical procedures is superior -transhiatal or transthoracic esophagectomy. Minimally invasive esophagectomy (MIE) could offer both minimally invasive approach and proper mediastinal lymph node dissection. Minimally invasive esophagectomy is safe and adequate, but time consuming and technically demanding procedure. It is procedure reserved for the surgeons experienced in open esophagectomy for cancer, and specially trained in advanced minimally invasive procedures. Even in that case, learning curve is steep.
INTRODUCTION
D espite the progress of other therapeutic options, surgery remains the first and the best therapy for esophageal cancer, whenever possible 1, 2 . When it comes to surgical treatment, some dilemmas achieved a consensus, while others are still subject of debate. It is generally accepted that the aim of surgical treatment is the removal of the esophagus with a tumor and the establishment of digestive continuity, in order to provide as early as possible an adequate oral food intake 3 . However, even though there is no possibility of adequate preoperative and intraoperative detection of the affected lymph nodes with tumor tissue, there are still doubts about the extent of lymph node dissection and optimal position of the esophagogastric anastomosis 4, 5 . That basically personifies the dilemma of whether to conduct the operation through a wide incision on the right thorax or without thoracotomy through transhiatal approach.
The advantage transthoracic approach is possibility to completely remove lymph nodes in the posterior mediastinum, and the drawback is the fact that the opening of the body cavity significantly increases operative trauma and cause specific complications. If the operation is performed without the opening of the chest (transhiatal), the operative trauma decreases, but it is impossible to remove the lymph nodes in the middle and upper mediastinum. Minimally invasive esophagectomy (MIE) summarizes the good features of both approaches: minimally invasive entrance to the chest, without a significant increase in surgical trauma and the possibility of adequate lymph node dissection on the posterior mediastinum 6 . The first written data about the thorascopic mobilization of the esophagus was published by Cushieri in 1992 7 . The first thoracoscopic esophageal mobilization due to cancer with two field standard lymph node dissection, at the Center for Esophageal Surgery in Belgrade, was performed in August 2009. The first large series of MIE with transhiatal approach was published by the Brazilian surgeon De Paola, analyzing the experience of the new procedure with 48 consecutive patients 8 . Currently the largest number of single series is attributed to James Luketich at UPMC ("Unversity of Pittsburgh Medical Center") in Pittsburgh with over 500 patients 9 . In this series surgical experience has evolved from the minimally invasive (MI) transhiatalesophagectomy, through laparoscopic and thoracoscopic esophagectomy with cervical anastomosis, to the minimally invasive (MI)Ivor Lewisprocedure, which is standard today.
The attempt to define the current position of MIE in the treatment of esophageal cancer is linked to numerous problems. The . Out of 1388 papers in English in which MIE is mentioned in the treatment of esophageal cancer, only 10 published papers fulfilled the criteria for the inclusion in the meta-analysis. These ten studies were further divided into five types of operations, e.g. five types of comparative analysis.These are: total MIE, thoracoscopic and laparoscopic esophagectomy with cervical esophagogastric anastomosis, thoracoscopic and laparoscopic or laparotomic esophagectomy with cervical anastomosis, laparosclopic transhiatal esophagectomy and hand-assisted laparoscopic transhiatal esophagectomy (Table 1) . Finally, in a certain number of studies it is not possible to define the extent of lymph node dissection in the posterior mediastinum 11 . It is clear that the results of the analysis designed in this manner, with highly heterogeneous data, are inconclusive. However, the analysis provides some of the answers that can currently represent a guideline for further work.
Most . A consensus exists as to the fact that the average blood loss during the MIE is significantly lower than with the open esophagectomy (OE), which is dictated by specific work techniques 6, 11 . The length of the stay in an intensive care unit and the hospital stay from surgery until the discharge from the hospital was also shorter with groups of patients which underwent MIE when compared to OE 10, 11 . The percentage of total complications was slightly lower in the group of patients that were operated with the MIE approach, but the difference when compared to the OE is not statistically significant 11 . When analyzing specific complications, pulmonary complications are less frequent in the group of patients that underwent MIE, but the difference is not statistically significant 11 . The problem in interpreting the incidence of pulmonary complications lies in a different classification of pulmonary complications in different studies. While a number of authors include only "major" complications (respiratory failure, etc.) in pulmonary complications, others include "minor" complications such as atelectasis, pleural effusion, etc. It is also interesting to note that the percentage of the esophagogastric anastomotic dehiscence is slightly lower in the group of patients which were operated by the MIE approach, but not even in this group is the complication of differences compared to OE statistically significant 11 . The reason for fewer complications in the MIE group is probably caused by the fact that the experience is on the side of MIE. The In the standard technique, the patient is initially positioned in dorsal decubitus and the laparoscopic procedure is performed with a five-trocars positioned specifically as the surgeon stands by the right side of the patient 16 . After complete gastric mobilization, the lymph nodes are removed from the celiac region and the left gastric artery is dividedat the point of origin 17 . Further along, the pyroloplasty, the creation of a tubulized gastric substitute, and abdominal act ends with the formation of feedingjejunostomy. Then the patient is turned on their left lateral decubitus, and the thoracic act is performed with a 4-5 trocar technique 16 .In doing so the esophagus with lymphadenectomy in the middle and lower level of the mediastinum ("two field standard lymph node dissection") is removed and by pulling-up the tubulized stomach through the hiatus,aintrathoracic stapledesophagogastric anastomosis is formed. A stapler is introduced through a 5cm long incision of right thorax. The same incision is used for specimen extraction afterwards 16 . What are the results of this series? Prior the esophagectomy 51% of patients underwent some sort of a neoadjuvant protocol, and as many as 25% had previous abdominal surgery. Esophagogastric anastomotic dehiscence in the thorax was verified with 6% of patients. We should bear in mind that this is the result obtained by analyzing the first 50 patients who underwent stapler intrathoracic anastomosis. The average stay in the intensive care unit was 1 day, and the average stay in the hospital from surgery to the discharge was 7 days. The total mortality in the series was 1.4%, a five-year survival of 36%, with the majority of patients were in the stage II and III of the disease.
Thoracoscopy with patients in the prone position provides a new perspective in the MIE approach. This position allows better exposure and ergonomics. The total number of trocars required for the thoracoscopic part of the surgery is reduced to 3 and the average duration of thoracoscopicesophagectomy with two field standard lymphadenectomy is approximately 1.5 hours 13 . Currently, Palaniveluet all from in Coimbator in India, has the greatest experience with MIE with the patient's in the prone position, who in 2006 published a series of 130 patients with thoracic esophageal carcinoma 18 .
CONCLUSION
Minimally invasive esophagectomy is a safe and oncologically adequate, but technically demanding and timeconsuming surgical procedure. It is reserved for surgeons with experience in open surgery of malignant disease of the esophagus and surgeons with significant experience in advanced laparoscopic procedures. Even then, the learning curve is long.
MIE is a procedure that is still evolving. Since the first experiences with the MIE procedures were published in the early nineties they have undergone many changes and innovations. What is the current status of the MIE? According to data of Boone et al. obtained by the survey which included 500 esophageal surgeons on three continents, as much as 40% had experience with one of MI techniques in the diagnosis and treatment of esophageal cancer 19 . Of all surgeons included in the survey, one third believes that MIE has an advantage over OE in the treatment of esophageal carcinoma.
In order to define the position of MIE in the treatment of esophageal carcinoma comprehensive multicentric randomized controlled studies are required. One such study is currently underway. The "Eastern Cooperative Oncology Group" study (ECOG 2202), a coordination centre located at the UPMC in Pittsburgh.
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SUMMARY MINIMALNO INVAZIVNE EZOFAGEKTOMIJE U LE^ENJU KARCINOMA JEDNJAKA
U zapadnoj populaciji incidence karcinoma jednjaka iznosi 3-6 novih slucajeva na 100.000 stanovnika. I pored napretka drugih terapijskih opcija hirurgija i dalje ostaje prva i najbolja terapija karcinoma jednjaka, kad god je to mogu}e. U dugom vremenskom period terapijska dilema odnosila se na procenu efekata dve raspolo'ive operativne procedure -transhijatalne ezofagektomije (THE) i transtorakalne ezofagektomije (TTE). Devedesetih godina prošlog veka u terapiju je uvedena nova hirurška opcija, minimalno invazivna ezofagektomija (MIE) koja je sublimirala dobre osobine oba pristupa i to minimalno invazivni ulazak u grudni koš, bez zna~ajnog uve}anja operativne traume i mogu}nost adekvatne limfonodalne disekcije zadnjeg medijastinuma. Minimalno invazivna ezofagektomija je sigurna i onkološki adekvatna, ali tehni~ki Br. 4 Minimally invasive esophagectomy in the treatment 29 of esophageal cancer i vremenski zahtev na hirurška procedura. Rezervisana je za hirurge sa iskustvom u otvorenoj hirurgiji malignih bolesti jednjaka i hirurge sa zna~ajnim iskustvom u naprednim laparoskopskim procedurama. ^ak i tada, kriva u~enja je duga.
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